Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Res

Retrieve available abstracts of 120 articles:
HTML format
Text format



Single Articles


    August 2018
  1. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Text format     Abstract available


  2. REEVES SR, Kang I, Chan CK, Barrow KA, et al
    Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.
    Respir Res. 2018;19:146.
    PubMed     Text format     Abstract available


  3. MOHEIMANI F, Koops J, Williams T, Reid AT, et al
    Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.
    Respir Res. 2018;19:145.
    PubMed     Text format     Abstract available


    July 2018
  4. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Text format     Abstract available


    June 2018
  5. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Text format     Abstract available


  6. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Text format     Abstract available


  7. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Text format     Abstract available


  8. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Text format     Abstract available


    May 2018
  9. JAAT FG, Hasan SF, Perry A, Cookson S, et al
    Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.
    Respir Res. 2018;19:106.
    PubMed     Text format     Abstract available


  10. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Text format     Abstract available


  11. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Text format     Abstract available


  12. GAO YH, Cui JJ, Wang LY, Yin KQ, et al
    Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.
    Respir Res. 2018;19:86.
    PubMed     Text format     Abstract available


  13. BULSEI J, Leroy S, Perotin JM, Mal H, et al
    Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).
    Respir Res. 2018;19:84.
    PubMed     Text format     Abstract available


    April 2018
  14. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Text format     Abstract available


    March 2018
  15. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Text format     Abstract available


  16. SAKORNSAKOLPAT P, Morrow JD, Castaldi PJ, Hersh CP, et al
    Integrative genomics identifies new genes associated with severe COPD and emphysema.
    Respir Res. 2018;19:46.
    PubMed     Text format     Abstract available


  17. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Text format     Abstract available


  18. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Text format     Abstract available


    February 2018
  19. OSTRIDGE K, Williams NP, Kim V, Harden S, et al
    Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD.
    Respir Res. 2018;19:31.
    PubMed     Text format     Abstract available


    January 2018
  20. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Text format     Abstract available


  21. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Text format     Abstract available


  22. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Text format     Abstract available


  23. MANORAK W, Idahosa C, Gupta K, Roy S, et al
    Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Respir Res. 2018;19:1.
    PubMed     Text format     Abstract available


    December 2017
  24. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Text format     Abstract available


  25. GRAMEGNA A, Amati F, Terranova L, Sotgiu G, et al
    Neutrophil elastase in bronchiectasis.
    Respir Res. 2017;18:211.
    PubMed     Text format     Abstract available


  26. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Text format     Abstract available


  27. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Text format     Abstract available


  28. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Text format     Abstract available


    November 2017
  29. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Text format     Abstract available


  30. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Text format     Abstract available


  31. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Text format     Abstract available


  32. ROCHA NN, de Oliveira MV, Braga CL, Guimaraes G, et al
    Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.
    Respir Res. 2017;18:185.
    PubMed     Text format     Abstract available


  33. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Text format     Abstract available


    September 2017
  34. MENENDEZ R, Mendez R, Polverino E, Rosales-Mayor E, et al
    Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
    Respir Res. 2017;18:176.
    PubMed     Text format     Abstract available


  35. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Text format     Abstract available


    August 2017
  36. SALTER B, Pray C, Radford K, Martin JG, et al
    Regulation of human airway smooth muscle cell migration and relevance to asthma.
    Respir Res. 2017;18:156.
    PubMed     Text format     Abstract available


  37. BLAIS CM, Davis BE, Cockcroft DW
    The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Respir Res. 2017;18:146.
    PubMed     Text format     Abstract available


    July 2017
  38. DEMARCHE SF, Schleich FN, Paulus VA, Henket MA, et al
    Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using biomarkers?
    Respir Res. 2017;18:133.
    PubMed     Text format     Abstract available


    June 2017
  39. BARRY LE, Sweeney J, O'Neill C, Price D, et al
    The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Respir Res. 2017;18:129.
    PubMed     Text format     Abstract available


    May 2017
  40. WEBLEY WC, Hahn DL
    Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.
    Respir Res. 2017;18:98.
    PubMed     Text format     Abstract available


  41. MALMSTROM K, Lohi J, Sajantila A, Jahnsen FL, et al
    Immunohistology and remodeling in fatal pediatric and adolescent asthma.
    Respir Res. 2017;18:94.
    PubMed     Text format     Abstract available


  42. RAVI AK, Plumb J, Gaskell R, Mason S, et al
    COPD monocytes demonstrate impaired migratory ability.
    Respir Res. 2017;18:90.
    PubMed     Text format     Abstract available


  43. PUNEKAR YS, Sharma S, Pahwa A, Takyar J, et al
    Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
    Respir Res. 2017;18:86.
    PubMed     Text format     Abstract available


  44. KOLSUM U, Donaldson GC, Singh R, Barker BL, et al
    Blood and sputum eosinophils in COPD; relationship with bacterial load.
    Respir Res. 2017;18:88.
    PubMed     Text format     Abstract available


  45. DOMINGO E, Grignola JC, Aguilar R, Messeguer ML, et al
    Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Respir Res. 2017;18:85.
    PubMed     Text format     Abstract available


  46. BODAS M, Vij N
    Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
    Respir Res. 2017;18:83.
    PubMed     Text format     Abstract available


  47. LAKHDAR R, Drost EM, MacNee W, Bastos R, et al
    2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controls.
    Respir Res. 2017;18:81.
    PubMed     Text format     Abstract available


  48. MURRAY LA, Dunmore R, Camelo A, Da Silva CA, et al
    Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.
    Respir Res. 2017;18:82.
    PubMed     Text format     Abstract available


  49. CEELEN JJM, Schols AMWJ, van Hoof SJ, de Theije CC, et al
    Differential regulation of muscle protein turnover in response to emphysema and acute pulmonary inflammation.
    Respir Res. 2017;18:75.
    PubMed     Text format     Abstract available


  50. DUIVERMAN ML, Maagh P, Magnet FS, Schmoor C, et al
    Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study.
    Respir Res. 2017;18:76.
    PubMed     Text format     Abstract available


  51. WEIDNER J, Jarenback L, de Jong K, Vonk JM, et al
    Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Respir Res. 2017;18:77.
    PubMed     Text format     Abstract available


    April 2017
  52. KOLSUM U, Ravi A, Hitchen P, Maddi S, et al
    Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
    Respir Res. 2017;18:73.
    PubMed     Text format     Abstract available


  53. OBEIDAT M, Nie Y, Chen V, Shannon CP, et al
    Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:72.
    PubMed     Text format     Abstract available


  54. MIRAVITLLES M, Ribera A
    Understanding the impact of symptoms on the burden of COPD.
    Respir Res. 2017;18:67.
    PubMed     Text format     Abstract available


  55. MATSUI H, Jo T, Fushimi K, Yasunaga H, et al
    Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan.
    Respir Res. 2017;18:68.
    PubMed     Text format     Abstract available


  56. JUNG KH, Torrone D, Lovinsky-Desir S, Perzanowski M, et al
    Short-term exposure to PM2.5 and vanadium and changes in asthma gene DNA methylation and lung function decrements among urban children.
    Respir Res. 2017;18:63.
    PubMed     Text format     Abstract available


  57. KHALAF RM, Lea SR, Metcalfe HJ, Singh D, et al
    Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Respir Res. 2017;18:61.
    PubMed     Text format     Abstract available


  58. KARL FM, Holle R, Bals R, Greulich T, et al
    Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Respir Res. 2017;18:60.
    PubMed     Text format     Abstract available


  59. CORDOBA-LANUS E, Cazorla-Rivero S, Espinoza-Jimenez A, de-Torres JP, et al
    Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
    Respir Res. 2017;18:59.
    PubMed     Text format     Abstract available


  60. CRUICKSHANK-QUINN C, Armstrong M, Powell R, Gomez J, et al
    Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate.
    Respir Res. 2017;18:57.
    PubMed     Text format     Abstract available


  61. BAKER K, Raemdonck K, Snelgrove RJ, Belvisi MG, et al
    Characterisation of a murine model of the late asthmatic response.
    Respir Res. 2017;18:55.
    PubMed     Text format     Abstract available


    March 2017
  62. LEVAN TD, Smith LM, Heires AJ, Mikuls TR, et al
    Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.
    Respir Res. 2017;18:49.
    PubMed     Text format     Abstract available


  63. ROOS AB, Mori M, Gura HK, Lorentz A, et al
    Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
    Respir Res. 2017;18:48.
    PubMed     Text format     Abstract available


  64. NAMBA Y, Togo S, Tulafu M, Kadoya K, et al
    Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
    Respir Res. 2017;18:46.
    PubMed     Text format     Abstract available


  65. NATARAJAN S, Free RC, Bradding P, McGarvey L, et al
    The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma.
    Respir Res. 2017;18:44.
    PubMed     Text format     Abstract available


    February 2017
  66. MARTINEZ CH, Freeman CM, Nelson JD, Murray S, et al
    GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Respir Res. 2017;18:42.
    PubMed     Text format     Abstract available


  67. SEYS SF, Scheers H, Van den Brande P, Marijsse G, et al
    Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.
    Respir Res. 2017;18:39.
    PubMed     Text format     Abstract available


  68. BAZZAN E, Turato G, Tine M, Radu CM, et al
    Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.
    Respir Res. 2017;18:40.
    PubMed     Text format     Abstract available


  69. BOULAY ME, Henry C, Bosse Y, Boulet LP, et al
    Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals.
    Respir Res. 2017;18:33.
    PubMed     Text format     Abstract available


  70. WESTERIK JA, Metting EI, van Boven JF, Tiersma W, et al
    Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.
    Respir Res. 2017;18:31.
    PubMed     Text format     Abstract available


    January 2017
  71. ZARCONE MC, van Schadewijk A, Duistermaat E, Hiemstra PS, et al
    Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
    Respir Res. 2017;18:27.
    PubMed     Text format     Abstract available


  72. CAZZOLA M, Calzetta L, Facciolo F, Rogliani P, et al
    Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
    Respir Res. 2017;18:26.
    PubMed     Text format     Abstract available


  73. MAKIKYRO EM, Jaakkola MS, Jaakkola JJ
    Subtypes of asthma based on asthma control and severity: a latent class analysis.
    Respir Res. 2017;18:24.
    PubMed     Text format     Abstract available


  74. FUJII U, Miyahara N, Taniguchi A, Oda N, et al
    Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma.
    Respir Res. 2017;18:23.
    PubMed     Text format     Abstract available


  75. BIHLET AR, Karsdal MA, Sand JM, Leeming DJ, et al
    Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Respir Res. 2017;18:22.
    PubMed     Text format     Abstract available


  76. GREEN CE, Turner AM
    The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).
    Respir Res. 2017;18:20.
    PubMed     Text format     Abstract available


  77. TAYEL SI, El-Hefnway SM, Abd El Gayed EM, Abdelaal GA, et al
    Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma.
    Respir Res. 2017;18:21.
    PubMed     Text format     Abstract available


  78. BLASI F, Canonica GW, Miravitlles M
    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Respir Res. 2017;18:19.
    PubMed     Text format     Abstract available


  79. AUGUSTO LS, Silva GC, Pinho JF, Aires RD, et al
    Vascular function in asthmatic children and adolescents.
    Respir Res. 2017;18:17.
    PubMed     Text format     Abstract available


  80. O'NEILL B, McDonough SM, Wilson JJ, Bradbury I, et al
    Comparing accelerometer, pedometer and a questionnaire for measuring physical activity in bronchiectasis: a validity and feasibility study?
    Respir Res. 2017;18:16.
    PubMed     Text format     Abstract available


  81. KAHNERT K, Lucke T, Biertz F, Lechner A, et al
    Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
    Respir Res. 2017;18:14.
    PubMed     Text format     Abstract available


  82. SALOMON J, Stolz D, Domenighetti G, Frey JG, et al
    Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
    Respir Res. 2017;18:13.
    PubMed     Text format     Abstract available


  83. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Text format     Abstract available


  84. REISNER C, Fabbri LM, Kerwin EM, Fogarty C, et al
    A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension Delivery Technology in patients with moderate-to-very severe chronic obstruct
    Respir Res. 2017;18:8.
    PubMed     Text format     Abstract available


  85. KIM SH, Pei QM, Jiang P, Yang M, et al
    Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
    Respir Res. 2017;18:7.
    PubMed     Text format     Abstract available


  86. DANG X, Qu X, Wang W, Liao C, et al
    Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:4.
    PubMed     Text format     Abstract available


  87. BATTAGLIA S, Scichilone N
    Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.
    Respir Res. 2017;18:5.
    PubMed     Text format     Abstract available


  88. SHUKLA SD, Mahmood MQ, Weston S, Latham R, et al
    The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL).
    Respir Res. 2017;18:6.
    PubMed     Text format     Abstract available


    December 2016
  89. LOZA MJ, Djukanovic R, Chung KF, Horowitz D, et al
    Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
    Respir Res. 2016;17:165.
    PubMed     Text format     Abstract available


  90. SULLIVAN A, Hunt E, MacSharry J, Murphy DM, et al
    'The Microbiome and the Pathophysiology of Asthma'.
    Respir Res. 2016;17:163.
    PubMed     Text format     Abstract available


    November 2016
  91. O'BYRNE PM, Jacques L, Goldfrad C, Kwon N, et al
    Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    Respir Res. 2016;17:157.
    PubMed     Text format     Abstract available


  92. KRAEMER R, Smith HJ, Sigrist T, Giger G, et al
    Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Respir Res. 2016;17:154.
    PubMed     Text format     Abstract available


  93. WANG M, Gao P, Wu X, Chen Y, et al
    Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.
    Respir Res. 2016;17:153.
    PubMed     Text format     Abstract available


  94. FRANZEN S, Janson C, Larsson K, Petzold M, et al
    Evaluation of the use of Swedish integrated electronic health records and register health care data as support clinical trials in severe asthma: the PACEHR study.
    Respir Res. 2016;17:152.
    PubMed     Text format     Abstract available


  95. TERASHITA T, Kobayashi K, Nagano T, Kawa Y, et al
    Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Respir Res. 2016;17:146.
    PubMed     Text format     Abstract available


    October 2016
  96. TAILLE C, Grootenboer-Mignot S, Estellat C, Roy C, et al
    Perip7lakin is a target for autoimmunity in asthma.
    Respir Res. 2016;17:126.
    PubMed     Text format     Abstract available


  97. SOUTHWORTH T, Plumb J, Gupta V, Pearson J, et al
    Anti-inflammatory potential of PI3Kdelta and JAK inhibitors in asthma patients.
    Respir Res. 2016;17:124.
    PubMed     Text format     Abstract available


    April 2016
  98. HOONHORST SJ, Lo Tam Loi AT, Pouwels SD, Faiz A, et al
    Advanced glycation endproducts and their receptor in different body compartments in COPD.
    Respir Res. 2016;17:46.
    PubMed     Text format     Abstract available


  99. MARTIN AL, Marvel J, Fahrbach K, Cadarette SM, et al
    The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
    Respir Res. 2016;17:40.
    PubMed     Text format     Abstract available


  100. HIMES BE, Weitzman ER
    Innovations in health information technologies for chronic pulmonary diseases.
    Respir Res. 2016;17:38.
    PubMed     Text format     Abstract available


  101. HADEBE S, Kirstein F, Fierens K, Redelinghuys P, et al
    beta-Glucan exacerbates allergic airway responses to house dust mite allergen.
    Respir Res. 2016;17:35.
    PubMed     Text format     Abstract available


    March 2016
  102. HAMPSON JA, Stockley RA, Turner AM
    Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.
    Respir Res. 2016;17:34.
    PubMed     Text format     Abstract available


  103. KOBAYASHI Y, Ito K, Kanda A, Tomoda K, et al
    Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity.
    Respir Res. 2016;17:30.
    PubMed     Text format     Abstract available


  104. LAI T, Wu D, Chen M, Cao C, et al
    YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling.
    Respir Res. 2016;17:31.
    PubMed     Text format     Abstract available


  105. CALVERLEY PM, Rennard SI, Clerisme-Beaty E, Metzdorf N, et al
    Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
    Respir Res. 2016;17:27.
    PubMed     Text format     Abstract available


  106. FILEP A, Fodor GH, Kun-Szabo F, Tiszlavicz L, et al
    Exposure to urban PM1 in rats: development of bronchial inflammation and airway hyperresponsiveness.
    Respir Res. 2016;17:26.
    PubMed     Text format     Abstract available


    February 2016
  107. SOHAL SS
    Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)?
    Respir Res. 2016;17:20.
    PubMed     Text format     Abstract available


  108. LUO J, Wang K, Liu D, Liang BM, et al
    Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis.
    Respir Res. 2016;17:18.
    PubMed     Text format     Abstract available


    January 2016
  109. GIANNAKAKI S, Politi L, Antonogiannaki EM, Spanakis N, et al
    Absence of human rhinovirus and respiratory syncytial virus from bronchoalveolar lavage and bronchial biopsies of selected patients with stable chronic obstructive pulmonary disease.
    Respir Res. 2016;17:11.
    PubMed     Text format     Abstract available


  110. GRUNDY S, Plumb J, Kaur M, Ray D, et al
    Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cells.
    Respir Res. 2016;17:9.
    PubMed     Text format     Abstract available


  111. ABE K, Sugiura H, Hashimoto Y, Ichikawa T, et al
    Possible role of Kruppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.
    Respir Res. 2016;17:7.
    PubMed     Text format     Abstract available


  112. SINGH JA, Yu S
    Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Respir Res. 2016;17:1.
    PubMed     Text format     Abstract available


  113. BRAIDO F, Brusselle G, Guastalla D, Ingrassia E, et al
    Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Respir Res. 2016;17:51.
    PubMed     Text format     Abstract available


  114. BAKER K, Raemdonck K, Dekkak B, Snelgrove RJ, et al
    Role of the ion channel, transient receptor potential cation channel subfamily V member 1 (TRPV1), in allergic asthma.
    Respir Res. 2016;17:67.
    PubMed     Text format     Abstract available


  115. MEBRATU YA, Smith KR, Agga GE, Tesfaigzi Y, et al
    Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
    Respir Res. 2016;17:75.
    PubMed     Text format     Abstract available


  116. NASSER S
    An imperfect "PAST" Lessons learned from the National Review of Asthma Deaths (NRAD) UK.
    Respir Res. 2016;17:87.
    PubMed     Text format     Abstract available


  117. OSTRIDGE K, Williams N, Kim V, Harden S, et al
    Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.
    Respir Res. 2016;17:92.
    PubMed     Text format     Abstract available


  118. EHTESHAMI-AFSHAR S, FitzGerald JM, Carlsten C, Tavakoli H, et al
    The impact of comorbidities on productivity loss in asthma patients.
    Respir Res. 2016;17:106.
    PubMed     Text format     Abstract available


  119. XU D, Wang Y, Chen Z, Li S, et al
    Prevalence and risk factors for asthma among children aged 0-14 years in Hangzhou: a cross-sectional survey.
    Respir Res. 2016;17:122.
    PubMed     Text format     Abstract available


  120. MOHEIMANI F, Hsu AC, Reid AT, Williams T, et al
    The genetic and epigenetic landscapes of the epithelium in asthma.
    Respir Res. 2016;17:119.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: